Zobrazeno 91 - 100
of 211
pro vyhledávání: ''
Autor:
Ana Bozas, Samuel Rochette, Wolfgang C. Winkelmayer, Bruce Spinowitz, Myrlene Sanon, Holly B. Krasa, Patrick Lefebvre, Gigi Shafai, Philippe Thompson-Leduc, Roberto Pecoits-Filho, Pablo E. Pergola
Publikováno v:
PharmacoEconomics Open
Background The cost and health-related quality of life (HRQoL) burden associated with treatments for anaemia of chronic kidney disease (CKD) is not well characterized among non-dialysis-dependent (NDD) patients. Objective Our objective was to review
Autor:
Willie Earley, Ágota Barabássy, Károly Acsai, Balázs Szatmári, Stefan Leucht, E. Szalai, István Laszlovszky, Judit Harsányi, György Németh
Publikováno v:
Neuropsychopharmacology
Understanding how rating scale improvement corresponds to a clinical impression in patients with negative symptoms of schizophrenia may help define the clinical relevance of change in this patient population. We conducted post hoc equipercentile link
Autor:
Filippo Zanetti, Keyur Trivedi, Yang Xiang, Utkarsh Doshi, Sandro Steiner, Laura Ortega Torres, Kyeonghee Monica Lee, Manuel C. Peitsch, Willie J. McKinney, Nikolai V. Ivanov, Florian Martin, Stefan Frentzel, Anita R. Iskandar, Patrice Leroy, Shoaib Majeed, Julia Hoeng, Celine Merg, Emmanuel Guedj, Athanasios Kondylis
Publikováno v:
Internal and Emergency Medicine
In the context of tobacco harm-reduction strategy, the potential reduced impact of electronic cigarette (EC) exposure should be evaluated relative to the impact of cigarette smoke exposure. We conducted a series of in vitro studies to compare the bio
Autor:
John D. Pritchard, Joseph Thompson, Donald W. Graff, Thomas Verron, Grant O’Connell, Tanvir Walele, Chris Prue
Publikováno v:
Internal and Emergency Medicine
E-cigarettes containing ‘nicotine salts’ aim to increase smoker’s satisfaction by improving blood nicotine delivery and other sensory properties. Here, we evaluated the pharmacokinetic profiles and subjective effects of nicotine from two e-ciga
Autor:
Alfredo Berrocal Kasay, Thomas Linde, Piotr Wiland, Elia Chalouhi El-Khouri, Sang Joon Lee, Pavel Shesternya, Francisco Fidenci Cons Molina, Janusz Jaworski, Ihor Hospodarskyy, Paweł Hrycaj, Jose Chavez-Corrales, Mauricio Abello-Banfi, Marek Brzosko, Sergii Shevchuk, Seung Cheol Shim, Dae Hyun Yoo, Armando Calvo, D. Andersone, Sławomir Jeka, Chang-Hee Suh, Sung Young Lee, Francisco G. Medina-Rodriguez, Pedro Miranda, Marek Krogulec, Won Park, Mariusz Piotrowski
Publikováno v:
Biodrugs
Objective The aim of this study was to investigate long-term clinical outcomes of extended treatment with CT-P10, a rituximab biosimilar, compared with rituximab reference products sourced from the USA and the EU (US-RTX and EU-RTX) in rheumatoid art
Autor:
Sheenu Chandwani, Fansen Kong, Min Huang, A. Simon Pickard, James M. Pellissier, Thomas Burke, M. Catherine Pietanza, A. Samkari
Publikováno v:
Pharmacoeconomics
Objectives Pembrolizumab monotherapy showed significantly longer overall survival and fewer treatment-related adverse events compared to chemotherapy in patients with advanced or metastatic non-small cell lung cancer (NSCLC) with programmed death lig
Publikováno v:
Drugs in R&D
Drugs in R&D, Vol 18, Iss 4, Pp 259-269 (2018)
Drugs in R&D, Vol 18, Iss 4, Pp 259-269 (2018)
Background and Objective Eosinophilic esophagitis (EE) is an immune/antigen-driven inflammation that causes esophageal dysfunction. Budesonide has shown promising effect in the management of EE in multiple studies, and we therefore conducted this sys
Autor:
Charles F. Gillespie, Vasiliki Michopoulos, Lucie Anne Duffy, Julia B. Merker, Antonia V. Seligowski, Murray B. Stein, Paul J. Marvar, Kerry J. Ressler
Publikováno v:
Neuropsychopharmacology
Prior observational studies have suggested that medications targeting the renin-angiotensin system, such as angiotensin-converting enzyme inhibitors (ACE-Is) and angiotensin receptor blockers (ARBs), may be associated with decreased PTSD symptoms. Gi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::347ae0a84ecc353bdb9a30fa055fe3bc
https://europepmc.org/articles/PMC8026983/
https://europepmc.org/articles/PMC8026983/
Autor:
Fabio Ferrarelli, Hoby P. Hetherington, Victor E. Yushmanov, Ahmad Mayeli, Gonzalo M. Quiñones
Publikováno v:
Neuropsychopharmacology
Youth at clinical high risk (CHR) are a unique population enriched for precursors of major psychiatric disorders, especially schizophrenia (SCZ). Recent neuroimaging findings point to abnormalities in the thalamus of patients with SCZ, including chro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b86fac062b06603eb4ca88f22f57a164
https://europepmc.org/articles/PMC8115482/
https://europepmc.org/articles/PMC8115482/
Autor:
Jamrozik, Euzebiusz, Selgelid, Michael
This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health i
Externí odkaz:
https://library.oapen.org/handle/20.500.12657/42913